Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical ...
The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...
Jan. 15, 2025 — Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...
It should come as no surprise that Alzheimer’s has touched ... living with the disease. By 2060, that number is projected to grow to nearly 14 million — doubling the current total ...
Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment ... based on current information and ...
The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve ...
Study reveals surprising connection between common childhood virus CMV and Alzheimer's disease, offering new insights into ...
Alzheimer's disease is the most common form of dementia, affecting more than three million Americans per year. And while its exact cause is unknown, researchers may have just had a breakthrough.
Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood ...
In a report released yesterday, Evan Seigerman from BMO Capital maintained a Hold rating on Biogen (BIIB – Research Report), with a price ...